World's Best Scientists 2026 revealed!
Régis Bordet

Régis Bordet

D-Index & Metrics

Neuroscience

D-Index
75
Citations
17094
World Ranking
2047
National Ranking
67

Medicine

D-Index
75
Citations
17102
World Ranking
19211
National Ranking
643

Overview

Régis Bordet is affiliated with the University of Lille in France and has a research focus primarily in the field of Medicine, with a substantial emphasis on Neurology. Their work spans numerous subfields including Neurology, Psychiatry and Mental Health, Epidemiology, Cognitive Neuroscience, and Physiology.

The scientist has contributed to multiple key topics in medical research, notably:

  • Dementia and Cognitive Impairment Research
  • Acute Ischemic Stroke Management
  • Alzheimer's disease research and treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Cerebrovascular and Carotid Artery Diseases
  • Genetic Associations and Epidemiology
  • Functional Brain Connectivity Studies

Their publication record includes papers appearing in various scientific journals. Some recent publications are:

  • Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts, 2021, The Lancet Neurology
  • Trial of Deferiprone in Parkinson's Disease, 2022, New England Journal of Medicine
  • Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19, 2020, Circulation
  • Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset, 2020, Translational Psychiatry
  • Analysis of the association of MPO and MMP-9 with stroke severity and outcome, 2020, Neurology

Frequent collaborators working alongside Bordet include Jill Richardson, Pieter Jelle Visser, Thibaut Dondaine, Philip Scheltens, and Sebastiaan Engelborghs. This indicates an active engagement in multidisciplinary research networks.

Regarding publication venues, Bordet's work has been frequently published in:

  • Therapies
  • Neurology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Alzheimer's & Dementia
  • Stroke

With a primary focus on neurological conditions, Bordet's research contributes to understanding complex disorders such as stroke, Alzheimer's disease, and Parkinson's disease, along with related cognitive and cerebrovascular conditions. The range of topics and venues also suggests integration of clinical and epidemiological perspectives in their scholarly output.

Best Publications

  • Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.

    Bruce Do Van;Flore Gouel;Aurélie Jonneaux;Kelly Timmerman

  • Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.

    Régis Bordet;Sophie Ridray;Suzanna Carboni;Jorge Diaz

  • PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.

    R. Bordet;T. Ouk;O. Petrault;P. Gelé

  • Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study

    David Devos;Kathy Dujardin;Isabelle Poirot;Caroline Moreau

  • Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment

    Dominique Deplanque;Patrick Gelé;Olivier Pétrault;Isabelle Six

  • Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.

    Nick A. Weaver;Hugo J. Kuijf;Hugo P. Aben;Jill Abrigo

  • Trial of Deferiprone in Parkinson's Disease.

    Unknown

  • Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

    Caroline Moreau;Arnaud Delval;Luc Defebvre;Kathy Dujardin

  • Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

    Louise Carton;Olivier Cottencin;Maryse Lapeyre-Mestre;Pierre-Alexis Geoffroy

  • Increase in Endogenous Brain Superoxide Dismutase as a Potential Mechanism of Lipopolysaccharide-Induced Brain Ischemic Tolerance

    Régis Bordet;Dominique Deplanque;Patrice Maboudou;François Puisieux

  • Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations

    J Jovicich;M Marizzoni;R Sala-Llonch;B Bosch

  • Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence.

    Jean-Charles Schwartz;Jorge Diaz;Régis Bordet;Nathalie Griffon

  • PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus

    Unknown

  • Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.

    Régis Bordet;Sophie Ridray;Jean-Charles Schwartz;Pierre Sokoloff

  • Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial

    David Devos;Caroline Moreau;David Maltête;Romain Lefaucheur

  • Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies

    Duncan Wilson;Gareth Ambler;Keon Joo Lee;Jae Sung Lim

  • Lipid lowering agents are associated with a slower cognitive decline in Alzheimer’s disease

    I Masse;R Bordet;D Deplanque;A Al Khedr

  • Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease

    D Devos;P Krystkowiak;F Clement;K Dujardin

  • Effect of Pindolol on Onset of Action of Paroxetine in the Treatment of Major Depression: Intermediate Analysis of a Double-Blind, Placebo-Controlled Trial

    Régis Bordet;Pierre Thomas;Bernard Dupuis

  • Polyunsaturated Fatty Acids Are Cerebral Vasodilators via the TREK-1 Potassium Channel

    Nicolas Blondeau;Olivier Pétrault;Stella Manta;Valérie Giordanengo

  • Heart rate variability and Parkinson's disease severity.

    D Devos;M Kroumova;R Bordet;H Vodougnon

  • Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

    Albert Fournier;Roxana Oprisiu-Fournier;Jean-Marie Serot;Olivier Godefroy

Frequent Co-Authors

Jill C. Richardson
Jill C. Richardson MSD (United Kingdom)
Didier Leys
Didier Leys University of Lille
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Giovanni B. Frisoni
Giovanni B. Frisoni University of Geneva
Charlotte Cordonnier
Charlotte Cordonnier University of Lille
Magda Tsolaki
Magda Tsolaki Aristotle University of Thessaloniki
Lars Bertram
Lars Bertram University of Lübeck
David Bartrés-Faz
David Bartrés-Faz University of Barcelona
Flavio Nobili
Flavio Nobili University of Genoa
Claudio Babiloni
Claudio Babiloni Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can open doors to a variety of exciting and lucrative careers. For those seeking flexibility and a fast track to their goals, several accelerated degree programs online offer neuroscience-related coursework. These programs allow students to complete their studies more efficiently while maintaining the quality of traditional on-campus education.

Students interested in financial outcomes may be curious about the highest paying bachelor degrees entry-level. Many neuroscience graduates pursue interdisciplinary roles in biotechnology, pharmaceuticals, and healthcare, which often rank among the most profitable degrees for early-career professionals.

Affordability is another key concern. Fortunately, there are many online college that accepts fafsa options, making accredited degree programs accessible even for students on a budget. Whether you’re accelerating your path or seeking top-paying roles, online neuroscience degrees create multiple pathways to rewarding careers.

Best Scientists Citing Régis Bordet

Trending Scientists